BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29100733)

  • 21. Synthesis, characterization, molecular modeling, and potential antimicrobial and anticancer activities of novel 2-aminoisoindoline-1,3-dione derivatives.
    Ahmed HE; Abdel-Salam HA; Shaker MA
    Bioorg Chem; 2016 Jun; 66():1-11. PubMed ID: 26986635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
    Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
    Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.
    Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA
    Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415.
    Zhang W; Chen B; Zhang Y; Li K; Hao K; Jiang L; Wang Y; Mou X; Xu X; Wang Z
    Biochem Biophys Res Commun; 2017 Jun; 487(3):494-499. PubMed ID: 28366631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of nitroaryl urea derivatives with antiproliferative properties.
    Wróbel TM; Kiełbus M; Kaczor AA; Kryštof V; Karczmarzyk Z; Wysocki W; Fruziński A; Król SK; Grabarska A; Stepulak A; Matosiuk D
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):608-18. PubMed ID: 26114307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides.
    Lal J; Gupta SK; Thavaselvam D; Agarwal DD
    Eur J Med Chem; 2013 Jun; 64():579-88. PubMed ID: 23685942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
    Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
    J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
    Sreelatha T; Kandhasamy S; Dinesh R; Shruthy S; Shweta S; Mukesh D; Karunagaran D; Balaji R; Mathivanan N; Perumal PT
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3647-51. PubMed ID: 24913712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs.
    El-Gohary NS; Shaaban MI
    Eur J Med Chem; 2017 Sep; 137():439-449. PubMed ID: 28623814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and identification of unprecedented selective inhibitors of CK1ε.
    Silveira-Dorta G; Sousa IJ; Fernandes MX; Martín VS; Padrón JM
    Eur J Med Chem; 2015; 96():308-17. PubMed ID: 25899335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
    Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C
    Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.
    Defaux J; Antoine M; Logé C; Le Borgne M; Schuster T; Seipelt I; Aicher B; Teifel M; Günther E; Gerlach M; Marchand P
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3748-52. PubMed ID: 25022204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
    El-Hawash SA; Wahab AE
    Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
    Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
    Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indolylmethylene benzo[h]thiazolo[2,3-b]quinazolinones: synthesis, characterization and evaluation of anticancer and antimicrobial activities.
    Gali R; Banothu J; Porika M; Velpula R; Hnamte S; Bavantula R; Abbagani S; Busi S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4239-42. PubMed ID: 25096298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.
    Peng W; Tu ZC; Long ZJ; Liu Q; Lu G
    Eur J Med Chem; 2016 Jan; 108():644-654. PubMed ID: 26731167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New imidazolidineiminothione derivatives: Synthesis, spectral characterization and evaluation of antitumor, antiviral, antibacterial and antifungal activities.
    Moussa Z; El-Sharief MAMS; Abbas SY
    Eur J Med Chem; 2016 Oct; 122():419-428. PubMed ID: 27393950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 4-arylaminoquinazoline derivatives with (E)-propen-1-yl moiety as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells.
    Chen L; Zhang Y; Liu J; Wang W; Li X; Zhao L; Wang W; Li B
    Eur J Med Chem; 2017 Sep; 138():689-697. PubMed ID: 28711703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.